Werewolf Therapeutics Inc share price logo

Werewolf Therapeutics Inc

NASDAQ: HOWL

Small Cap

$0.64

-0.02

(-3.75%)

as on

Werewolf Therapeutics Inc Stock Performance

as on May 13, 2026 at 6:58 am IST

  • Day's Low

    Day's High

    $0.62
    $0.68
    downward going graph

    3.13%

    Downside

    6.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.53
    $2.38
    downward going graph

    17.17%

    Downside

    271.87%

    Upside

    downward going graph

Werewolf Therapeutics Inc share price movements today

Previous Close
$0.66
Open
$0.66
Volume
785.2K
Day's Low - High
$0.62 - $0.68
52 Week Low - High
$0.53 - $2.38

Werewolf Therapeutics Inc Historical Returns

1 Month Return
-22.2 %
3 Month Return
+ 0.23 %
1 Year Return
-33.95 %
3 Year Return
-77.53 %
5 Year Return
-94.88 %

Werewolf Therapeutics Inc Stock Fundamentals & Key Indicators

Check Werewolf Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$33.0M

EPS (TTM)

-1.08

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-54.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-161.89%

Werewolf Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Werewolf Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Werewolf Therapeutics Inc image
Werewolf Therapeutics Inc
BUY$33.0M-94.88%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.4B113.59%74.1312.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.2BNA70.468.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.1B104.61%25.5135.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.9B40.55%17.4529.65%

Stock Returns calculator for Werewolf Therapeutics Inc Stock including INR - Dollar returns

The Werewolf Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Werewolf Therapeutics Inc investment value today

Current value as on today

₹72,093

Returns

-₹27,907

(-27.91%)

Returns from Werewolf Therapeutics Inc Stock

-₹36,000 (-36%)

Dollar Impact

₹8,093 (+8.09%)

Analyst Recommendation on Werewolf Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Werewolf Therapeutics Inc. Average target price of $7

Werewolf Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Werewolf Therapeutics Inc.

What analysts predicted

90.86%UPSIDE

Target Price

$7

Current Price

$0.64

Analyzed by

12 Analysts

Target

$7.00

Werewolf Therapeutics Inc target price $7, a slight upside of 90.86% compared to current price of $0.64. According to 12 analysts rating.

Indian Investors' Interest in Werewolf Therapeutics Inc Stock

Search interest for Werewolf Therapeutics Inc Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-29% versus previous 30 day period

Werewolf Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
1
0
1
0
0
-
-
-
-
Gross Profit
1
0
0
0
0
0
0
-
0
Operating Income
-12
-17
-18
-17
-20
-17
-17
-15
-9
EBITDA
-10
-14
-15
-14
-18
-16
-16
-15
-6
Interest Expense
1
1
1
1
1
1
1
0
1
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-16
-17
-16
-20
-18
-17
-16
-8
Income Tax Expense
2
0
-
-
-
-
-
-
-
Net Income
-12
-16
-17
-16
-20
-18
-17
-16
-8
Net Profit Margin
-799.67%
-2182.35%
-1509.10%
-34026.53%
41632.65%
0.00%
0.00%
0.00%
0.00%

Werewolf Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
4
16
19
1
-
Gross Profit
0
0
0
16
18
0
-1
Operating Income
-9
-22
-50
-56
-40
-73
-60
EBITDA
-9
-14
-49
-54
-32
-64
-59
Interest Expense
0
0
0
1
3
4
5
Depreciation
0
0
0
1
1
1
1
Income Before Tax
-10
-15
-49
-53
-37
-70
-60
Income Tax Expense
0
0
0
-2
1
-
-
Net Income
-10
-14
-49
-51
-37
-70
-60
Net Profit Margin
0.00%
0.00%
-1199.78%
-314.40%
-187.37%
-3740.85%
0.00%

Werewolf Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-16
-17
-16
-20
-18
-17
-16
-8
-13
Operating Cash Flow
-15
-14
-12
-14
-18
-15
-15
-11
-10
Investing Cash Flow
0
0
0
0
-
-
-
-
-
Financing Cash Flow
20
-9
0
2
-
0
3
2
-
Change in Cash
4
-23
-12
-11
-18
-14
-11
-8
-10

Werewolf Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-49
-53
-37
-70
-60
Operating Cash Flow
-18
-42
-40
-32
-56
-60
Investing Cash Flow
0
0
-3
0
0
-
Financing Cash Flow
93
109
15
58
13
6
Change in Cash
74
66
-28
25
-43
-54

Global Institutional Holdings in Werewolf Therapeutics Inc

Funds
Holdings
MPM Oncology Impact Management LP
2.87%
Millennium Management LLC
0.49%
BlackRock Inc
0.21%
Vanguard Group Inc
2.9%
Renaissance Technologies Corp
1.39%
See all

Insights on Werewolf Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 38.3% return, outperforming this stock by 73.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.4% return, outperforming this stock by 107.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 1.14M → -49.0K (in $), with an average decrease of 147.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -8.38M → -13.53M (in $), with an average decrease of 61.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, HOWL stock has moved down by -28.0%

About Werewolf Therapeutics Inc

Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. In addition, it develops WTX-1011, a conditionally activated INDUCER T cell engager molecule that targets STEAP 1 for prostate cancer, as well as WTX-2022 that targets CDH6 for ovarian and kidney cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
OrganisationWerewolf Therapeutics Inc
Headquarters200 Talcott Ave, Watertown, MA, United States, 02472
IndustryBiotechnology
CEODr. Daniel J. Hicklin Ph.D.
E-voting on sharesClick here to vote

Key Management of Werewolf Therapeutics Inc

Name

Title

Dr. Daniel J. Hicklin Ph.D.

Founder, CEO, President, Secretary & Director

Mr. Michael Urban

VP of Finance, Corporate Controller, Principal Financial Officer & Principal Accounting Officer

Mr. Steven H. Bloom R.Ph.

Chief Business Officer

FAQs

What is Werewolf Therapeutics Inc share price today?

Werewolf Therapeutics Inc share price today is $0.64 as on at the close of the market. Werewolf Therapeutics Inc share today touched a day high of $0.68 and a low of $0.62.

What is the 52 week high and 52 week low for Werewolf Therapeutics Inc share?

Werewolf Therapeutics Inc share touched a 52 week high of $2.38 on and a 52 week low of $0.53 on . Werewolf Therapeutics Inc stock price today i.e. is closed at $0.64,which is 73.11% down from its 52 week high and 20.73% up from its 52 week low.

What is Werewolf Therapeutics Inc's market capitalisation today?

Werewolf Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Werewolf Therapeutics Inc Stock (HOWL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Werewolf Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Werewolf Therapeutics Inc Shares that will get you 2.3438 shares as per Werewolf Therapeutics Inc share price of $0.64 per share as on May 13, 2026 at 1:28 am IST.

What is the minimum amount required to buy Werewolf Therapeutics Inc Stock (HOWL) from India?

Indian investors can start investing in Werewolf Therapeutics Inc (HOWL) shares with as little as ₹95.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Werewolf Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Werewolf Therapeutics Inc share’s latest price of $0.64 as on May 13, 2026 at 1:28 am IST, you will get 15.6250 shares of Werewolf Therapeutics Inc. Learn more about fractional shares .

What are the returns that Werewolf Therapeutics Inc has given to Indian investors in the last 5 years?

Werewolf Therapeutics Inc stock has given -94.88% share price returns and 29.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?